SNTI - Senti Biosciences, Inc.
0.9649
0.027 2.777%
Share volume: 150,605
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$0.94
0.03
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-14-2024 | 03-20-2025 | 05-06-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 102.185 M | 86.913 M | 57.721 M | 97.841 M | 82.778 M | 52.685 M | |
| Current Assets | 55.666 M | 44.339 M | 17.384 M | 58.961 M | 45.213 M | 18.158 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 14.020 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 14.020 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 17.923 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 23.723 M | 15.860 M | 10.479 M | 48.277 M | 33.802 M | 12.243 M | |
| Total Non-current Assets | 46.519 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 24.354 M | 23.253 M | 22.218 M | 21.289 M | 20.533 M | 18.691 M | |
| Other Assets | 16.266 M | 19.321 M | 18.119 M | 17.591 M | 17.032 M | 15.836 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 102.185 M | 86.913 M | 57.721 M | 97.841 M | 82.778 M | 52.685 M | |
| Total liabilities | 46.091 M | 42.765 M | 41.727 M | 47.086 M | 44.919 M | 44.564 M | |
| Total current liabilities | 9.609 M | 9.068 M | 9.064 M | 13.146 M | 10.726 M | 12.027 M | |
| Accounts Payable | 1.624 M | 3.742 M | 3.771 M | 7.725 M | 5.402 M | 6.874 M | |
| Other liabilities | 4.037 M | 33.697 M | 32.663 M | 33.940 M | 34.193 M | 32.537 M | |
| Current long term debt | 4.278 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 32.445 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 4.037 M | 33.697 M | 32.663 M | 33.940 M | 34.193 M | 32.537 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 56.094 M | 44.148 M | 15.994 M | 25.649 M | 37.859 M | 8.121 M | |
| Common stock | 45.709 M | 311.806 M | 312.518 M | 322.783 M | 349.105 M | 352.226 M | |
| Retained earnings | -256.455 M | -267.658 M | -296.524 M | -297.134 M | -311.246 M | -344.105 M |